Christina Tsalapaki, Argyro Lazarini, Evaggelia Argyriou, Vassiliki Dania, Kyriaki Boki, Gerasimos Evangelatos, Alexios Iliopoulos, Maria Pappa, Petros P Sfikakis, Maria G Tektonidou, Athanasios Georgountzos, Euripidis Kaltsonoudis, Paraskevi Voulgari, Alexandros A Drosos, Evaggelos Theotikos, Charalampos Papagoras, Theodoros Dimitroulas, Alexandros Garyfallos, Evaggelia Kataxaki, Georgios Vosvotekas, Dimitrios Boumpas, Emilia Hadziyannis, Dimitrios Vassilopoulos
The rates of relapses and therapy discontinuation in patients with giant cell arteritis (GCA) in the modern therapeutic era have not been defined. We aimed to evaluate the glucocorticoid (GC) discontinuation rate and the factors associated with relapses in a contemporary GCA cohort. Patient and treatment data were collected cross-sectionally at first evaluation and 2 years later (second evaluation), in a multicenter, prospective GCA cohort. Predictors of relapses were identified by logistic regression analyses...
February 1, 2024: Rheumatology International